BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, December 30, 2025
Home » Authors » Jim Stommen

Jim Stommen

Articles

ARTICLES

The MDD Interview: Genomind eyes a change in psychiatry's trial-and-error approach

Jan. 31, 2013
By Jim Stommen
Dr. Jay Lombard, a neurologist, is the co-founder and chief scientific officer of Genomind (Chalfont, Pennsylvania), a company focused on improving the lives of patients with psychiatric and neurological conditions through biomarker discovery. Lombard has researched and developed several novel therapeutic interventions to treat depression, dementia, and autism.
Read More

The MDD Interview: Given sticks to noninvasive imaging roots as it eyes new ground

Jan. 24, 2013
By Jim Stommen
Nachum (Homi) Shamir is president/CEO of Given Imaging (Yokneam, Israel), whose U.S. operations are located in Duluth, Georgia. Shamir joined the company in April 2006, prior to which he served as corporate VP of Eastman Kodak and as president of Eastman Kodak's Transaction and Industrial Solutions Group, which includes several business units, among them Kodak Versamark (whose operations were previously those of Scitex Digital Printing), of which he was president/CEO. From June 2003-January 2004, he was president/CEO of Scitex Corp., and before Scitex held senior management positions at various international companies, mainly in the Asia-Pacific regions.
Read More

The MDD Interview: It's a Given this company brought new thinking to GI imaging

Jan. 17, 2013
By Jim Stommen
Nachum (Homi) Shamir is president/CEO of Given Imaging (Yokneam, Israel), whose U.S. operations are located in Duluth, Georgia. Shamir joined the company in April 2006, prior to which he served as corporate VP of Eastman Kodak and as president of Eastman Kodak's Transaction and Industrial Solutions Group, which includes several business units, among them Kodak Versamark (whose operations were previously those of Scitex Digital Printing), of which he was president and CEO. From June 2003-January 2004, he was president/CEO of Scitex Corp., and before Scitex held senior management positions at various international companies, mainly in the Asia-Pacific regions.
Read More

The MDD Interview: For retail clinic users, success reflected by receipt of care

Jan. 10, 2013
By Jim Stommen
Ateev Mehrotra, MD, joined the faculty of the University of Pittsburgh in 2006. He is an associate professor of medicine in the Division of General Internal Medicine. Mehrotra also is a health policy researcher with RAND Corp. His research focuses include the measurement and public reporting of healthcare quality and efficiency, pay-for-performance incentives, and consumer-directed healthcare.
Read More

The MDD Interview: Researcher/physician sees growing impact for retail clinics

Jan. 3, 2013
By Jim Stommen
Ateev Mehrotra, MD, joined the faculty of the University of Pittsburgh in 2006. He is an associate professor of medicine in the Division of General Internal Medicine. Mehrotra also is a health policy researcher with RAND Corp. His research focuses include the measurement and public reporting of healthcare quality and efficiency, pay-for-performance incentives, and consumer-directed healthcare.
Read More

Dubreuil: Usability playing a larger role in designing products

Dec. 27, 2012
By Jim Stommen
Marc Dubreuil is director of business development at Farm, a Hollis, New Hampshire-based product development firm that focuses on medical and life sciences. He has held numerous positions within the plastics and manufacturing industries, and has a strong background in the product development process.
Read More

The MDD Interview: Dubreuil tills product development soil for concepts to grow at Farm

Dec. 20, 2012
By Jim Stommen
Marc Dubreuil is director of business development at Farm, a Hollis, New Hampshire-based consultancy that focuses on medical and life sciences product development. He has held numerous positions within the plastics and manufacturing industries, and has a strong background in the product development process.
Read More

The MDD Interview: With heart and lung trials, it's an 'exciting time' for TransMedics

Dec. 13, 2012
By Jim Stommen
Waleed Hassanein, MD, is president, CEO and a director of TransMedics (Andover, Massachusetts). He founded the company in 1998 and led it through the clinical development, market launch and commercial rollout of the breakthrough Organ Care System (OCS) technology. The OCS is a medical device used for ex-vivo physiologic preservation and assessment of transplantable organs, in both the European and U.S. markets.
Read More

The MDD Interview: Hassanein eyes a major role in success of organ transplants

Dec. 6, 2012
By Jim Stommen

The MDD Interview: Molineaux sees growth opportunities for life sciences in PA

Nov. 29, 2012
By Jim Stommen
Christopher Molineaux is president of Pennsylvania Bio, the only statewide trade association for the life sciences industry whose membership includes medical device, diagnostic, biotechnology, pharmaceutical and research organizations. Prior to joining Pennsylvania Bio in September 2009, he served as worldwide vice president of pharmaceutical communication and public affairs for Johnson & Johnson.
Read More
View All Articles by Jim Stommen

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 29, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 29, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing